User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions

→‎Brain cancer and cannabis: + a '''2004''' study, published in w:Molecular Pharmacology titled 'Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells'
(→‎Brain cancer and cannabis: + a '''2008''' '''review''', published in "Expert review on neurotherapies" titled 'Cannabinoids as potential new therapy for the treatment of gliomas')
(→‎Brain cancer and cannabis: + a '''2004''' study, published in w:Molecular Pharmacology titled 'Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells')
Line 259: Line 259:


* [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]]
* [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]]
* [http://www.ncbi.nlm.nih.gov/pubmed/15361550 'Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2004''' study, published in [[w:Molecular Pharmacology]]


* [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2001''' study published in [[w:Cancer Research (journal)]]
* [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2001''' study published in [[w:Cancer Research (journal)]]
9,842

edits